⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAPR News
Capricor Therapeutics Inc
Securities Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
CAPR
Pomerantz LLP Advises of Securities Class Action Involving Capricor Therapeutics, Inc. – CAPR
accessnewswire.com
CAPR
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
accessnewswire.com
CAPR
Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) – Contact Levi & Korsinsky Before September 28, 2026
accessnewswire.com
CAPR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Reach Out
accessnewswire.com
CAPR
CAPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CAPR
Contact Levi & Korsinsky by September 28, 2026 to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)
accessnewswire.com
CAPR
Levi & Korsinsky Urges Capricor Therapeutics, Inc. (CAPR) Shareholders to Act Before Lead Plaintiff Deadline September 28, 2026
accessnewswire.com
CAPR
Pomerantz LLP Advises of Securities Class Action Against Capricor Therapeutics, Inc. – CAPR
accessnewswire.com
CAPR
Capricor Therapeutics, Inc. (CAPR) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before September 28, 2026
accessnewswire.com
CAPR